Modulation of Brain Rhythms in Stroke
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Aug 6, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This research study is looking at how the brain and muscles work together in people who have had a stroke, especially focusing on improving hand strength and control. The study will test whether a gentle, non-invasive type of brain stimulation—kind of like a mild electrical signal—applied to different parts of the brain can help improve communication between the brain and muscles during a hand-squeezing task.
To take part, individuals must have had one stroke at least six months ago that affected one side of their body, causing weakness in their hand or arm. Participants also need to have good thinking skills, be able to understand and follow instructions in English, and be able to make a fist with their weaker hand. The study involves one visit lasting about three hours. During this time, participants will wear a special cap that measures brain activity and small stickers on their arm to measure muscle activity. They will complete several rounds of hand squeezing, sometimes receiving brain stimulation just before squeezing. The study will also include some simple tests to check mood, movement ability, and thinking skills. This is an early-stage study and is not yet recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • One and only one chronic (≥ 6 months) unilateral cortical/subcortical ischemic or hemorrhagic stroke as confirmed by medical records
- • Upper extremity weakness (hemiparesis) contralateral to the stroke
- • Sufficient cognitive capacity (Montreal Cognitive Assessment ≥ 26 points), communication function, and English proficiency to understand and safely comply with all study procedures
- • Ipsilesional motor-evoked potential response
- • Able to perform isometric grip task by making a fist with their stroke-affected hand (hand contralateral to the stroke)
- Exclusion Criteria:
- • Contraindications to TMS (seizure activity within past 2 years, pregnancy, indwelling metal)
- • Cognitive deficits (Montreal Cognitive Assessment \< 26 points)
- • Concurrent physical/occupational therapy and/or clinical trial participation
- • Injury or conditions that impact affected extremity-use beyond stroke (e.g., arthritis)
- • Impaired vision despite use of aid (e.g. glasses, contacts, etc.)
- • Cerebellar stroke
- • Major medical/neurological/psychiatric condition impacting physical function in the opinion of the physician co-investigator
- • Absent ipsilesional motor-evoked potential response
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Jessica M Cassidy, DPT, PT, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported